Skip to content

Predictors of Pain Relief From Mindfulness-based Stress Reduction (MBSR) in Multiple Forms of Chronic Pain Patients

Predictors of Pain Relief From Mindfulness-based Stress Reduction in Multiple Forms of Chronic Pain Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04981925
Enrollment
381
Registered
2021-07-29
Start date
2021-08-01
Completion date
2025-02-27
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain Syndrome

Keywords

chronic pain, rheumatoid arthritis, fibromyalgia, neuropathy, neuralgia, pain

Brief summary

The overall objective of this study is to better understand how Mindfulness-based Stress Reduction (MBSR) is the most helpful in terms of management of chronic pain symptoms. The studies hypothesis is that an Interventional Response Phenotyping study (light phenotyping) can identify individuals with different underlying mechanisms for their pain who thus respond differentially to evidence-based interventions for chronic pain disorders.

Detailed description

Participants enrolled in this study will receive 8 weeks of MBSR therapy and complete surveys at various time points pre-treatment - post treatment.

Interventions

BEHAVIORALMBSR treatment

Participants will complete pre-treatment surveys followed by 8-weekly 2-hour group sessions and one 4-hour retreat (may take place virtually or in-person). Participants will also be asked to practice daily formal mindfulness at home using assigned audio recordings of 30-45 minute guided mindfulness exercises. Participants will complete surveys during treatment as well as after treatment and then at 2 months follow-up.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for MBSR Study * Ages 18+ * Any form of self-reported chronic pain (except cancer related pain)

Exclusion criteria

for MBSR study * Unable to speak and write English * Visual or hearing difficulties that would preclude participation * Chronic pain from cancer.

Design outcomes

Primary

MeasureTime frameDescription
PROMIS physical function 6b8 weeks (after MSBR)Physical Function 6b questionnaire will assess self-reported capability with 6 qualitatively scaled questions ranked on a 5-point scale, from without any difficulty to unable to do or not at all to cannot do. The minimum raw summed score is 6 and the maximum score is 30. Lower scores suggest better outcomes.

Secondary

MeasureTime frameDescription
Change in PROMIS pain intensity, anxiety, pain interferenceBaseline (pre-treatment), 8 weeksChange from baseline in pain interference (QoL), measured by PROMIS Pain Interference 6a. Measure of the amount of interference pain causes in life; range 6-30; higher is worse
Change in Pain Catastrophizing Scale (PCS)Baseline (pre-treatment), 8 and 12 weeksThe PCS is a 13-item questionnaire that inquires about thoughts and feelings a patient experiences when in pain. Responses are recorded on a 5-point Likert scale (not at all to all the time). A total score is yielded ranging from 0-52. Higher score is associated with worse outcome.
Pain Catastrophizing Score; measured with Pain Catastrophizing Scale8 weeks (after MSBR)The PCS is a 13-item questionnaire that inquires about thoughts and feelings a patient experiences when in pain. Responses are recorded on a 5-point Likert scale (not at all to all the time). A total score is yielded ranging from 0-52. Higher score is associated with worse outcome
Change in Chronic Pain Acceptance Questionnaire (CPAQ)-8Baseline, 8 weeks (after MSBR)CPAQ-8 is an 8-item questionnaire with a score range 0-48 with higher scores indicating better status. Change score is computed by subtracting baseline CPAQ-8 score from score at time of reassessment. Improvement is indicated by change scores with positive values.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026